Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints.
Authors: Menarim Bruno C, Gillis Kiersten H, Oliver Andrea, Ngo Ying, Werre Stephen R, Barrett Sarah H, Rodgerson Dwayne H, Dahlgren Linda A
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Synovial inflammation drives osteoarthritis progression, with macrophages acting as key orchestrators that can either maintain joint health or perpetuate disease depending on their activation state. Menarim and colleagues examined synovial tissue biopsies and fluid from 29 healthy and 26 osteoarthritic equine joints using immunohistochemistry and multiplex cytokine analysis to characterise macrophage phenotypes and their associated inflammatory mediators. Whilst all macrophage markers (CD14, CD86, CD206, IL-10) were expressed in both groups, osteoarthritic joints exhibited elevated monocyte chemoattractant protein-1 (MCP-1) and notably *reduced* interleukin-10 and stromal-derived factor-1 in synovial fluid, despite similar prostaglandin E2 concentrations—suggesting the regulatory capacity of resident macrophages becomes exhausted rather than fundamentally altered in phenotype. The finding that increased macrophage expression correlated proportionately with synovial inflammation severity, particularly for pro-inflammatory CD86 markers, indicates that therapeutic strategies targeting inflammation *resolution* rather than suppression alone may prove superior, potentially by restoring the anti-inflammatory signalling and recruitment signals that fail in chronic OA. These observations have important implications for farriers and veterinarians managing arthritic patients: they support investigating novel interventions that actively stimulate pro-resolving mechanisms rather than relying solely on conventional anti-inflammatory approaches.
Read the full abstract on PubMed
Practical Takeaways
- •Chronic joint inflammation in osteoarthritis appears driven by loss of macrophage homeostatic function rather than a simple M1/M2 shift; future treatments should focus on restoring resolution mechanisms rather than just suppressing inflammation.
- •Measuring synovial fluid IL-10 and MCP-1 ratios may help identify joints where inflammatory resolution has failed and guide intervention timing.
- •Current anti-inflammatory approaches may be insufficient; consider therapeutic strategies that actively promote tissue healing and inflammatory resolution once diagnosis is confirmed.
Key Findings
- •Macrophage phenotypes (M1/M2) in equine synovium show minimal differences between osteoarthritic and healthy joints, with expression increasing proportionally to synovial inflammation.
- •Osteoarthritic joints demonstrated elevated MCP-1 and reduced IL-10 and SDF-1α in synovial fluid, suggesting overwhelmed homeostatic mechanisms.
- •CD86 expression increased most markedly with synovial inflammation and was strongly associated with synovial hyperplasia.
- •Pro-resolving therapies targeting macrophage phenotype and inflammatory resolution may offer improved outcomes for osteoarthritis treatment.